Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

July 27, 2015

Primary Completion Date

June 27, 2016

Study Completion Date

September 13, 2016

Conditions
Diabetes Type 2
Interventions
DRUG

ORMD-0801

Oral Insulin

DRUG

Placebo Comparator

Placebo

Trial Locations (34)

10018

New York Clinical Trials, New York

29615

Upstate Pharmaceutical Research, Greenville

32174

Ormond Medical Arts Pharmaceutical Research Center, Ormond Beach

33013

Research in Miami Inc., Hialeah

Research in Miami, Inc., Hialeah

33165

Phoenix Medical Research LLC, Miami

33401

Metabolic Research Institute, Inc, West Palm Beach

33603

Clinical Research of West Florida, Inc., Tampa

33634

Meridien Research, Tampa

33765

Clinical Research of West Florida, Inc., Clearwater

34208

Meridien Research, Bradenton

34601

Meridien Research, Brooksville

48504

Apex Medical Research, MI, Inc, Flint

67207

Heartland Research Associates, LLC, Wichita

72204

Arkansas Primary Care Clinic, PA, Little Rock

73069

Lynn Institute of Norman, Norman

78215

Sun Research Institute, San Antonio

78221

Southwest Clinic, San Antonio

78228

Panacea Clinical Research, San Antonio

78229

Clinical Trials of Texas, Inc., San Antonio

78404

Padre Coast Clinical Research, Corpus Christi

80209

Creekside Endocrine Associates, PC, Denver

84107

Wasatch Clinical Research, LLC, Salt Lake City

85015

Steingard Medical Group, Phoenix

89106

Impact Clinical Trials, Las Vegas

90017

ACTCA, Inc., Los Angeles

90036

ACTCA, Los Angeles

90057

National Research Institute, Los Angeles

91606

Providence Clinical Research, North Hollywood

92780

Orange County Research Center, Tustin

92801

Dream Team Clinical Research, Anaheim

94401

Mills-Peninsula Health Services, San Mateo

98057

Rainier Clinical Research Center, Inc., Renton

04210

Maine Research Associates, Auburn

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Integrium

INDUSTRY

lead

Oramed, Ltd.

INDUSTRY